These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15373207)

  • 1. [Prospective comparative study on protective effect of the proton pump inhibitor and the prostaglandin analog on H. pylori-negative gastric mucosa of healthy subjects against low-dose aspirin].
    Kotaira J
    Hokkaido Igaku Zasshi; 2004 Jul; 79(4):347-51. PubMed ID: 15373207
    [No Abstract]   [Full Text] [Related]  

  • 2. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pariet in current patterns of eradication of Helicobacter pylori infection].
    Baranskaia EK
    Voen Med Zh; 2001 Apr; 322(4):54-8. PubMed ID: 11547668
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
    Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug interactions. Proton pump inhibitors II].
    Zaigler M
    Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.
    Nishino M; Sugimoto M; Kodaira C; Yamade M; Uotani T; Shirai N; Ikuma M; Tanaka T; Sugimura H; Hishida A; Furuta T
    J Clin Pharmacol; 2011 Jul; 51(7):1079-86. PubMed ID: 20663999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative efficacy of proton pump inhibitors in children].
    Kornienko EA; Klochko OG
    Eksp Klin Gastroenterol; 2003; (6):72-5. PubMed ID: 15065532
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
    Törüner M; Bektaş M; Cetinkaya H; Soykan I; Ozden A
    Turk J Gastroenterol; 2004 Dec; 15(4):225-8. PubMed ID: 16249975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injury.
    Donnelly MT; Goddard AF; Filipowicz B; Morant SV; Shield MJ; Hawkey CJ
    Aliment Pharmacol Ther; 2000 May; 14(5):529-34. PubMed ID: 10792114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Choice of proton pump inhibitors--does it play any role?].
    Hellström PM
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2620-1. PubMed ID: 15534636
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastroprotective activity of the novel proton pump inhibitor lansoprazole in the rat.
    Morini G; Grandi D; Arcari ML; Bertaccini G
    Gen Pharmacol; 1995 Sep; 26(5):1021-5. PubMed ID: 7557244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In high risk patients cyclooxygenase inhibitor plus proton pump inhibitor].
    Bolten WW
    MMW Fortschr Med; 2003 Jan; 145(5):9. PubMed ID: 12619199
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs.
    Weaver AL; Gitlin N
    Arch Intern Med; 2002 Oct; 162(19):2248-9. PubMed ID: 12390074
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
    Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against aspirin-induced gastric lesions by lansoprazole: simultaneous evaluation of functional and morphologic responses.
    Bergmann JF; Chassany O; Simoneau G; Lemaire M; Segrestaa JM; Caulin C
    Clin Pharmacol Ther; 1992 Oct; 52(4):413-6. PubMed ID: 1424414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
    Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
    Drugs Exp Clin Res; 2000; 26(2):41-5. PubMed ID: 10894554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.